MPO
MOLECULAR TARGETmyeloperoxidase
MPO (myeloperoxidase) is targeted by 8 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting MPO
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Quercetin | 1.61 | 4 |
| 2 | Metoclopramide | 1.61 | 4 |
| 3 | Isoniazid Antibacterial agent used primarily as | 1.10 | 2 |
| 4 | Apigenin 5,7,4'-trihydroxy-flavone, | 0.69 | 1 |
| 5 | Kaempferols | 0.69 | 1 |
| 6 | Melatonin | 0.69 | 1 |
| 7 | Dapsone | 0.69 | 1 |
| 8 | Tryptophan | 0.69 | 1 |
About MPO as a Drug Target
MPO (myeloperoxidase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 8 compounds with documented MPO interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
MPO inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.